Simultaneous Detection and Differentiation of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Viruses in Respiratory Specimens Using the VitaSIRO <i>solo</i>™ SARS-CoV-2/Flu/RSV Assay.

Diagnostics (Basel) · 2025 · PMC12428728 · PMID 40941736

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The usability results were comparable for VitaSIRO solo TM Instrument and Cepheid GeneXpert ® Xpress System, with slight differences, which, however, did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Simultaneous Detection and Differentiation of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Viruses in Respiratory Specimens Using the VitaSIRO &lt;i&gt;solo&lt;/i&gt;™ SARS-CoV-2/Flu/RSV Assay.

The sentences

Simultaneous Detection and Differentiation of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Viruses in Respiratory Specimens Using the VitaSIRO <i>solo</i>™ SARS-CoV-2/Flu/RSV Assay.